Testimonials

Find out what companies around the world are saying about working with us.
Client location
Client location with testimonial
Algorithme Pharma is an important partner in our development efforts and we recommend them for any ligand-binding requirements. Bryan Tayefeh | Assistant Director Alliance Management Ionis Pharmaceuticals, Inc. Read full testimonial
We have also been very pleased with their record of timely recruitment, including ensuring an inventory of back-up study participants. Hélène Dulude, B.Pharm., Ph.D. Director, Clinical Development Locemia Solutions ULC Read full testimonial
...the communication between our teams was optimal, from the first protocol draft to the delivery of final report. Maxime Ranger President and CEO gIcare pharma inc Read full testimonial
It was easy to work with them and they were always willing to take the time to discuss any concerns and respond to questions. Marie-Francoise TEMAM Associate Director, Clinical Operations Idenix, a wholly-owned subsidiary of Merck & Company Read full testimonial
I recommend this site because of the expertise and quality of trials performed. Okba Haj-Ali Saflo Clinical Research Scientist Chemo Group Read full testimonial

I am writing to recommend the services of Algorithme Pharma. I have been using Algorithme Pharma services to conduct a Proof of Concept Phase I/Ila study in the therapeutic area of the Hepatic C Virus Infection starting in September 2013 and ending in January 2015.

They did an excellent job for this study: they were the 2nd better recruiter of HCV-infected subjects among 6 sites worldwide, always very transparent in their communication and with a focus on the quality.

As proofs of their performance:

  1. They completed the first part of the study in sequential dose escalation of Healthy Volunteers ( 48) and Genotype 1 HCV-infected subjects (15) in less than 3 months from regulatory submission to last subject dosed.
  2. They also successfully participated in the multiple dosing of several genotype HCV -infected subjects and delivered 6 subjects within 2 months in a highly competitive environment.
  3. A sponsor audit of their systems at the CRO offices and the Phase I Unit was conducted on June 2014 (4 days) and no major finding was found. Only 4 minor audit observations and one comment were raised which proves the high quality standards of Algorithme Pharma.

The team members from Algorithme Pharma were responsive, hard-working and client oriented. It was easy to work with them and they were always willing to take the time to discuss any concerns and respond to questions.

I feel confident in recommending Algorithme Pharma services.

If you need additional information please feel free to contact me.

Marie-Francoise TEMAM
Associate Director, Clinical Operations
Idenix, a wholly-owned subsidiary of Merck & Company